市場調査レポート

商品コード

1687600

末梢動脈疾患の市場規模、シェア、成長分析：タイプ別、治療法別、疾患別、投与経路別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Peripheral Artery Disease Market Size, Share, and Growth Analysis, By Type, By Treatment, By Disease, By Route of Administration, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年03月18日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

末梢動脈疾患の市場規模は2023年に53億米ドルと評価され、2024年の58億5,000万米ドルから2032年には129億1,000万米ドルに成長し、予測期間（2025年～2032年）のCAGRは10.4%で成長する見通しです。

2023年10月現在、40歳以上のアメリカ人のうち約650万人が末梢動脈疾患（PAD）に罹患しており、アフリカ系アメリカ人の罹患率が高いことが市場調査で明らかになっています。高齢化社会は、加齢とともにリスクが高まるため、PAD患者の増加を大きく後押ししています。この人口動態の変化と同時に、PADの診断、管理、治療を目的とした製品の承認が急増しています。このような要因の組み合わせがPAD発症の全体的なリスクを高めており、加齢に関連した動向、疾患有病率の増加、ヘルスケアにおける技術の進歩が複雑に絡み合っていることを浮き彫りにしています。米国で増大するPADの負担に効果的に対処しようとする利害関係者にとって、こうした力学を理解することは極めて重要です。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022年～2024年）

主要企業プロファイル

Medtronic plc（Ireland）
Abbott Laboratories（USA）
Boston Scientific Corporation（USA）
Becton, Dickinson and Company（BD）（USA）
Philips（Netherlands）
Terumo Corporation（Japan）
Cook Medical（USA）
Cardinal Health, Inc.（USA）
B. Braun Melsungen AG（Germany）
Getinge AB（Sweden）
Merit Medical Systems, Inc.（USA）
BIOTRONIK SE & Co. KG（Germany）
Endologix, Inc.（USA）
Gore Medical（USA）
Penumbra, Inc.（USA）
AngioDynamics, Inc.（USA）
Johnson & Johnson（USA）
Bayer AG（Germany）

結論と提言

Product Code: SQMIG35A2750

Peripheral Artery Disease Market size was valued at USD 5.3 billion in 2023 and is poised to grow from USD 5.85 billion in 2024 to USD 12.91 billion by 2032, growing at a CAGR of 10.4% during the forecast period (2025-2032).

As of October 2023, market insights reveal that around 6.5 million Americans aged 40 and older are living with Peripheral Artery Disease (PAD), with heightened susceptibility observed among African Americans. The aging population significantly drives the rise in PAD cases, as risks increase with age. In tandem with this demographic shift, there has been a surge in product approvals aimed at the diagnosis, management, and treatment of PAD. This combination of factors enhances the overall risk of developing PAD, highlighting the complex interplay of age-related trends, increasing disease prevalence, and technological advancements in healthcare. Understanding these dynamics is crucial for stakeholders aiming to address the growing burden of PAD in the United States effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Artery Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Artery Disease Market Segments Analysis

Global Peripheral Artery Disease Market is segmented by Type, Treatment, Disease, Route of Administration, End User and region. Based on Type, the market is segmented into Peripheral Angioplasty Balloons, Plaque Modification Devices, Peripheral Stents, Peripheral Catheters, Hemodynamic Flow Alteration Devices, Inferior Vena Cava (IVC) Filters and Peripheral Accessories. Based on Treatment, the market is segmented into Device, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Others. Based on Disease, the market is segmented into Lipid Lowering Drugs, Triple-H Therapy, Glucose Regulating Drugs, Blood Clot Preventing Drugs,, Inotropes,, Thrombolytic Agents, and Anti-Inflammatory Agents. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Artery Disease Market

The growing prevalence of elderly individuals affected by diabetes and hypertension serves as a critical driver for the peripheral artery disease (PAD) market. Older adults are especially vulnerable to vascular complications, and the presence of these chronic conditions significantly heightens the risk of developing PAD. Diabetes and hypertension contribute to the narrowing and hardening of arterial walls, which in turn restricts blood flow to the limbs, thus increasing the likelihood of PAD. As the number of seniors facing these health challenges continues to rise, the demand for effective PAD treatments and interventions is anticipated to grow, further propelling the market forward.

Restraints in the Peripheral Artery Disease Market

The anticipated recurrence of peripheral artery disease (PAD) following treatment is expected to present a significant barrier to the growth of the peripheral artery disease market in the upcoming years. Despite advancements in medical technology and treatment options, the risk of PAD relapse remains a considerable obstacle to continuous market development. Moreover, concerns related to product recalls within the industry may exacerbate difficulties for the PAD market in the short term. Such recalls can undermine consumer trust, invite increased regulatory scrutiny, and require corrective actions, all of which can hinder overall market growth and stability. Addressing these challenges will necessitate a collaborative approach from stakeholders to effectively manage disease and ensure product safety, thereby supporting the ongoing development of effective therapies for peripheral artery disease.

Market Trends of the Peripheral Artery Disease Market

The Peripheral Artery Disease (PAD) market is poised for significant growth, driven by the increasing prevalence of the disease and a surge in product approvals by regulatory bodies. As PAD, characterized by the narrowing of arteries that supply blood to the limbs, continues to affect a larger segment of the population, the demand for advanced diagnostic and therapeutic solutions becomes paramount. Recent advancements in medical technologies yield innovative treatments and management strategies, directly addressing the complexities of PAD. This favorable landscape indicates a robust market expansion, creating substantial opportunities for stakeholders in the healthcare sector over the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Peripheral Artery Disease Market Size by Type & CAGR (2025-2032)

Market Overview
Peripheral Angioplasty Balloons
Plaque Modification Devices
Peripheral Stents
Peripheral Catheters
Hemodynamic Flow Alteration Devices
Inferior Vena Cava (IVC) Filters
Peripheral Accessories

Global Peripheral Artery Disease Market Size by Treatment & CAGR (2025-2032)

Market Overview
Device
- Stents
- Balloons
- Atherectomy Devices
Catheters
- Drug-Eluting Catheters
- Balloon Catheters
- Guidewires
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Others

Global Peripheral Artery Disease Market Size by Disease & CAGR (2025-2032)

Market Overview
Lipid Lowering Drugs
Triple-H Therapy
Glucose Regulating Drugs
Blood Clot Preventing Drugs,
Inotropes,
Thrombolytic Agents,
Anti-Inflammatory Agents

Global Peripheral Artery Disease Market Size by Route of Administration & CAGR (2025-2032)

Market Overview
Oral
Parenteral
Others

Global Peripheral Artery Disease Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals & Clinics
Ambulatory Surgical Clinics

Global Peripheral Artery Disease Market Size & CAGR (2025-2032)

North America (Type, Treatment, Disease, Route of Administration, End User)
- US
- Canada
Europe (Type, Treatment, Disease, Route of Administration, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Treatment, Disease, Route of Administration, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Treatment, Disease, Route of Administration, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Treatment, Disease, Route of Administration, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gore Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

末梢動脈疾患の市場規模、シェア、成長分析：タイプ別、治療法別、疾患別、投与経路別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Peripheral Artery Disease Market Size, Share, and Growth Analysis, By Type, By Treatment, By Disease, By Route of Administration, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

世界の末梢動脈疾患市場規模：タイプ別・CAGR（2025年～2032年）

世界の末梢動脈疾患市場規模：治療法別・CAGR（2025年～2032年）

世界の末梢動脈疾患市場規模：疾患別・CAGR（2025年～2032年）

世界の末梢動脈疾患市場規模：投与経路別・CAGR（2025年～2032年）

世界の末梢動脈疾患市場規模：エンドユーザー別・CAGR（2025年～2032年）

世界の末梢動脈疾患市場規模・CAGR（2025年～2032年）